Krystal Biotech (KRYS) Revenue (2023 - 2026)
Krystal Biotech (KRYS) posted quarterly Revenue of $119.2 million for Q2 2026, up 24.14% year-over-year from $96.0 million in Q2 2025, and up 2.42% on a QoQ basis from $116.4 million in Q1 2026.
Krystal Biotech (KRYS) Revenue (2023 - 2026) Analysis & Trends
Krystal Biotech has reported Revenue for 4 years, with the latest figure at $119.2 million in Q2 2026.
- Revenue for Q2 2026 came in at $119.2 million, up 24.14% year-over-year; the trailing twelve-month figure through Jun 2026 was $440.5 million (up 22.64% YoY), and the FY2025 annual result was $389.1 million, up 33.94% from the prior year.
- Revenue improved to $119.2 million in Q2 2026, from $116.4 million in the prior quarter.
- Over five years, Revenue peaked at $119.2 million in Q2 2026 and troughed at $8.6 million in Q3 2023.
- A 4-year average of $80.5 million and a median of $89.7 million in 2024 frame the typical range for Revenue.
- The widest annual swing landed in 2024, when Revenue soared 879.91%; it then rose 16.65% in 2025.
- A 4-year view of Revenue shows it stood at $42.1 million in 2023, then jumped by 116.2% to $91.1 million in 2024, then increased by 17.55% to $107.1 million in 2025, then advanced by 11.31% to $119.2 million in 2026.
- Per Business Quant data, the three most recent Revenue figures were $119.2 million in Q2 2026, $116.4 million in Q1 2026, and $107.1 million in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 3.33 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 4.29 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 1.56 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 1.71 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 3,001.92 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 674.14 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 1.29 Bn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 425.49 Mn |
| 10 | Krystal Biotech | 9.83 Bn | 8.99 Bn | 112.79 Mn | 119.22 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 119.22 Mn |
| Mar 31, 2026 | 116.40 Mn |
| Dec 31, 2025 | 107.11 Mn |
| Sep 30, 2025 | 97.80 Mn |
| Jun 30, 2025 | 96.04 Mn |
| Mar 31, 2025 | 88.18 Mn |
| Dec 31, 2024 | 91.14 Mn |
| Sep 30, 2024 | 83.84 Mn |
| Jun 30, 2024 | 70.30 Mn |
| Mar 31, 2024 | 45.25 Mn |
| Dec 31, 2023 | 42.14 Mn |
| Sep 30, 2023 | 8.56 Mn |